[Efficacy of alverina citrate and simethicone combination in abdominal pain and discomfort of irritable bowel syndrome].

T. Wittmann, L. Paradovsky, P. Ducrotte, L. Bueno, M. C. Andro-Delestrain

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The alverina citrate and simethicone combination (ACS-Meteospazmil) is used for irritable bowel syndrome (IBS) for almost 20 years, but the supporting scientific evidence for efficacy is limited. to evaluate the effectiveness of ACS in patients with abdominal pain and discomfort at IBS. In a double-blind, randomized, placebo-controlled study enrolled 412 patients with IBS conform to Rome criteria III. Selection criterion in the study was to evaluate the intensity of abdominal pain or discomfort during the 2-week run-in period without medication, which according to analog scale (VAS) was to be 60-100 mm. With the help of an interactive voice communication system (IVCS), patients were randomized to treatment with either alverin citrate 60 mg with Simethicone 300 mg three times daily or corresponding placebo for 4 weeks. For analyze of the results of the study were selected 409 patients. After 4 weeks, patients treated with ACS, was observed lower scores in the VAS assessment of abdominal pain or discomfort compared to placebo (mean--40 and 50 mm, p = 0.047) and a higher level of response to treatment (46.8% and 34.3%, respectively). Recorded side effects were similar in both groups. The combination of ACS was significantly more effective in patients with IBS compared to placebo in reducing abdominal pain or discomfort.

Original languageEnglish
Pages (from-to)60-67
Number of pages8
JournalĖksperimental'naia i klinicheskaia gastroėnterologiia = Experimental & clinical gastroenterology
Issue number3
Publication statusPublished - 2011

Fingerprint

Simethicone
Irritable Bowel Syndrome
Citric Acid
Abdominal Pain
Placebos
Patient Selection
Communication
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{5f05eb203a704318aace1a004911f84b,
title = "[Efficacy of alverina citrate and simethicone combination in abdominal pain and discomfort of irritable bowel syndrome].",
abstract = "The alverina citrate and simethicone combination (ACS-Meteospazmil) is used for irritable bowel syndrome (IBS) for almost 20 years, but the supporting scientific evidence for efficacy is limited. to evaluate the effectiveness of ACS in patients with abdominal pain and discomfort at IBS. In a double-blind, randomized, placebo-controlled study enrolled 412 patients with IBS conform to Rome criteria III. Selection criterion in the study was to evaluate the intensity of abdominal pain or discomfort during the 2-week run-in period without medication, which according to analog scale (VAS) was to be 60-100 mm. With the help of an interactive voice communication system (IVCS), patients were randomized to treatment with either alverin citrate 60 mg with Simethicone 300 mg three times daily or corresponding placebo for 4 weeks. For analyze of the results of the study were selected 409 patients. After 4 weeks, patients treated with ACS, was observed lower scores in the VAS assessment of abdominal pain or discomfort compared to placebo (mean--40 and 50 mm, p = 0.047) and a higher level of response to treatment (46.8{\%} and 34.3{\%}, respectively). Recorded side effects were similar in both groups. The combination of ACS was significantly more effective in patients with IBS compared to placebo in reducing abdominal pain or discomfort.",
author = "T. Wittmann and L. Paradovsky and P. Ducrotte and L. Bueno and Andro-Delestrain, {M. C.}",
year = "2011",
language = "English",
pages = "60--67",
journal = "Rossiiskii gastroenterologicheskii zhurnal : ezhekvartalnyi nauchno-prakticheskii zhurnal",
issn = "1682-8658",
publisher = "Anakharsis",
number = "3",

}

TY - JOUR

T1 - [Efficacy of alverina citrate and simethicone combination in abdominal pain and discomfort of irritable bowel syndrome].

AU - Wittmann, T.

AU - Paradovsky, L.

AU - Ducrotte, P.

AU - Bueno, L.

AU - Andro-Delestrain, M. C.

PY - 2011

Y1 - 2011

N2 - The alverina citrate and simethicone combination (ACS-Meteospazmil) is used for irritable bowel syndrome (IBS) for almost 20 years, but the supporting scientific evidence for efficacy is limited. to evaluate the effectiveness of ACS in patients with abdominal pain and discomfort at IBS. In a double-blind, randomized, placebo-controlled study enrolled 412 patients with IBS conform to Rome criteria III. Selection criterion in the study was to evaluate the intensity of abdominal pain or discomfort during the 2-week run-in period without medication, which according to analog scale (VAS) was to be 60-100 mm. With the help of an interactive voice communication system (IVCS), patients were randomized to treatment with either alverin citrate 60 mg with Simethicone 300 mg three times daily or corresponding placebo for 4 weeks. For analyze of the results of the study were selected 409 patients. After 4 weeks, patients treated with ACS, was observed lower scores in the VAS assessment of abdominal pain or discomfort compared to placebo (mean--40 and 50 mm, p = 0.047) and a higher level of response to treatment (46.8% and 34.3%, respectively). Recorded side effects were similar in both groups. The combination of ACS was significantly more effective in patients with IBS compared to placebo in reducing abdominal pain or discomfort.

AB - The alverina citrate and simethicone combination (ACS-Meteospazmil) is used for irritable bowel syndrome (IBS) for almost 20 years, but the supporting scientific evidence for efficacy is limited. to evaluate the effectiveness of ACS in patients with abdominal pain and discomfort at IBS. In a double-blind, randomized, placebo-controlled study enrolled 412 patients with IBS conform to Rome criteria III. Selection criterion in the study was to evaluate the intensity of abdominal pain or discomfort during the 2-week run-in period without medication, which according to analog scale (VAS) was to be 60-100 mm. With the help of an interactive voice communication system (IVCS), patients were randomized to treatment with either alverin citrate 60 mg with Simethicone 300 mg three times daily or corresponding placebo for 4 weeks. For analyze of the results of the study were selected 409 patients. After 4 weeks, patients treated with ACS, was observed lower scores in the VAS assessment of abdominal pain or discomfort compared to placebo (mean--40 and 50 mm, p = 0.047) and a higher level of response to treatment (46.8% and 34.3%, respectively). Recorded side effects were similar in both groups. The combination of ACS was significantly more effective in patients with IBS compared to placebo in reducing abdominal pain or discomfort.

UR - http://www.scopus.com/inward/record.url?scp=79960172027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960172027&partnerID=8YFLogxK

M3 - Article

C2 - 21698811

AN - SCOPUS:79960172027

SP - 60

EP - 67

JO - Rossiiskii gastroenterologicheskii zhurnal : ezhekvartalnyi nauchno-prakticheskii zhurnal

JF - Rossiiskii gastroenterologicheskii zhurnal : ezhekvartalnyi nauchno-prakticheskii zhurnal

SN - 1682-8658

IS - 3

ER -